New York, NY, United States of America

Erica K Benson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erica K Benson. Retrieved from https://idiyas.com/inventor/erica-k-benson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Erica K Benson: Innovator in Cancer Treatment

Introduction

Erica K Benson is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer treatment. With a focus on innovative methods for addressing tumors, her work has the potential to impact many lives.

Latest Patents

Erica holds a patent for the "Treatment of Hippo Pathway Mutant Tumors and Methods of Identifying Subjects as Candidates for Treatment." This invention relates to a method of treating tumors in subjects with Hippo pathway mutant tumors by administering a tankyrase inhibitor. The method is designed to identify subjects who are candidates for this treatment, showcasing her commitment to advancing cancer therapies.

Career Highlights

Erica K Benson is affiliated with the Icahn School of Medicine at Mount Sinai, where she conducts her research and develops her innovative treatments. Her work is characterized by a dedication to improving patient outcomes through scientific discovery.

Collaborations

Some of her notable coworkers include Stuart A Aaronson and Albino Troilo, who contribute to the collaborative environment that fosters innovation in cancer research.

Conclusion

Erica K Benson's contributions to cancer treatment through her patented methods highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in the treatment of tumors, demonstrating the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…